Hamartoma articles from across Nature Portfolio

Latest Research and Reviews

• 

  Rapamycin-upregulated miR-29b promotes mTORC1-hyperactive cell growth in TSC2-deficient cells by downregulating tumor suppressor retinoic acid receptor β (RARβ)

  • Heng-Jia Liu
  • Hilaire C. Lam
  • Elizabeth P. Henske

  Research16 Aug 2019 Oncogene

  Volume: 38, P: 7367-7383
• 

  Wnt/β-catenin signaling, which is activated in odontomas, reduces Sema3A expression to regulate odontogenic epithelial cell proliferation and tooth germ development

  • Shinsuke Fujii
  • Kengo Nagata
  • Naohisa Wada

  ResearchOpen Access12 Mar 2019 Scientific Reports

  Volume: 9, P: 4257
• 

  Rapalog resistance is associated with mesenchymal-type changes in Tsc2-null cells

  • Matthildi Valianou
  • Natalia Filippidou
  • Aristotelis Astrinidis

  ResearchOpen Access28 Feb 2019 Scientific Reports

  Volume: 9, P: 3015
• 

  Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2

  • David J Kwiatkowski
  • Michael R Palmer
  • Julian R Sampson

  ResearchOpen Access18 Mar 2015 European Journal of Human Genetics

  Volume: 23, P: 1665-1672
• 

  Analysis of gene expression array in TSC2-deficient AML cells reveals IRF7 as a pivotal factor in the Rheb/mTOR pathway

  • V Makovski
  • J Jacob-Hirsch
  • Y Kloog

  ResearchOpen Access04 Dec 2014 Cell Death & Disease

  Volume: 5, P: e1557
• 

  Sirolimus treatment of severe PTEN hamartoma tumor syndrome: case report and in vitro studies

  • Gordian L. Schmid
  • Franziska Kässner
  • Antje Garten

  Research23 Dec 2013 Pediatric Research

  Volume: 75, P: 527-534